KR20060118509A - 신규 화합물 - Google Patents

신규 화합물 Download PDF

Info

Publication number
KR20060118509A
KR20060118509A KR1020067010242A KR20067010242A KR20060118509A KR 20060118509 A KR20060118509 A KR 20060118509A KR 1020067010242 A KR1020067010242 A KR 1020067010242A KR 20067010242 A KR20067010242 A KR 20067010242A KR 20060118509 A KR20060118509 A KR 20060118509A
Authority
KR
South Korea
Prior art keywords
hfa
cyclodextrin
alkyl
drug
cyclodextrins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067010242A
Other languages
English (en)
Korean (ko)
Inventor
필리페 로구에다
Original Assignee
아스트라제네카 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스트라제네카 아베 filed Critical 아스트라제네카 아베
Publication of KR20060118509A publication Critical patent/KR20060118509A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020067010242A 2003-11-26 2004-11-24 신규 화합물 Ceased KR20060118509A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303179-6 2003-11-26
SE0303179A SE0303179D0 (sv) 2003-11-26 2003-11-26 Novel compounds

Publications (1)

Publication Number Publication Date
KR20060118509A true KR20060118509A (ko) 2006-11-23

Family

ID=29729189

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067010242A Ceased KR20060118509A (ko) 2003-11-26 2004-11-24 신규 화합물

Country Status (23)

Country Link
US (1) US20070104652A1 (https=)
EP (1) EP1708679B1 (https=)
JP (1) JP4950666B2 (https=)
KR (1) KR20060118509A (https=)
CN (1) CN100592908C (https=)
AT (1) ATE413868T1 (https=)
AU (1) AU2004294775B2 (https=)
BR (1) BRPI0416992A (https=)
CA (1) CA2546441C (https=)
CY (1) CY1108753T1 (https=)
DE (1) DE602004017783D1 (https=)
DK (1) DK1708679T3 (https=)
ES (1) ES2314469T3 (https=)
IL (1) IL175659A (https=)
MX (1) MXPA06005643A (https=)
NO (1) NO20062969L (https=)
NZ (1) NZ547355A (https=)
PL (1) PL1708679T3 (https=)
PT (1) PT1708679E (https=)
SE (1) SE0303179D0 (https=)
SI (1) SI1708679T1 (https=)
WO (1) WO2005053637A2 (https=)
ZA (1) ZA200604330B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
WO2023127219A1 (ja) * 2021-12-28 2023-07-06 リンテック株式会社 シリコーン系粘着剤、粘着シートおよび両面粘着シート

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
US5654442A (en) * 1989-11-14 1997-08-05 The Perkin-Elmer Corporation 4,7-dichlorofluorescein dyes as molecular probes
TW224942B (https=) * 1990-04-04 1994-06-11 Adka Ueno Kk
EP0477931B1 (en) * 1990-09-28 1994-08-17 Mercian Corporation Novel adriamycin derivatives
FR2692168B1 (fr) * 1992-06-16 1995-03-24 Centre Nat Rech Scient Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères.
US5916883A (en) * 1996-11-01 1999-06-29 Poly-Med, Inc. Acylated cyclodextrin derivatives
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DE10205087A1 (de) * 2002-02-07 2003-08-21 Pharmatech Gmbh Cyclodextrine als Suspensionsstabilisatoren in druckverflüssigten Treibmitteln

Also Published As

Publication number Publication date
CA2546441A1 (en) 2005-06-16
CA2546441C (en) 2011-11-22
IL175659A0 (en) 2006-09-05
WO2005053637A3 (en) 2007-06-28
DE602004017783D1 (de) 2008-12-24
CN100592908C (zh) 2010-03-03
NZ547355A (en) 2009-05-31
CN101087600A (zh) 2007-12-12
US20070104652A1 (en) 2007-05-10
NO20062969L (no) 2006-08-25
JP4950666B2 (ja) 2012-06-13
IL175659A (en) 2010-02-17
SI1708679T1 (sl) 2009-04-30
AU2004294775B2 (en) 2007-12-20
AU2004294775A1 (en) 2005-06-16
ES2314469T3 (es) 2009-03-16
EP1708679A2 (en) 2006-10-11
DK1708679T3 (da) 2009-02-16
MXPA06005643A (es) 2006-08-17
PT1708679E (pt) 2008-12-29
CY1108753T1 (el) 2014-04-09
HK1108390A1 (zh) 2008-05-09
WO2005053637A2 (en) 2005-06-16
JP2007515401A (ja) 2007-06-14
ZA200604330B (en) 2007-11-28
BRPI0416992A (pt) 2007-02-06
PL1708679T3 (pl) 2009-04-30
SE0303179D0 (sv) 2003-11-26
ATE413868T1 (de) 2008-11-15
EP1708679B1 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
JP6348645B2 (ja) ２つ以上の活性剤を呼吸器送達するための組成物、方法および系
Myrdal et al. Advances in metered dose inhaler technology: formulation development
EP1731140B1 (en) Medicinal aerosol formulation
KR20140032404A (ko) ２ 개 이상의 활성제의 호흡기 전달을 위한 조성물, 방법 ＆ 시스템
DE60225421T9 (de) Inhalator mit mitteln zur verbesserung der chemischen stabilität einer darin enthaltenen medizinischen aerosollösung
AU2021314977B2 (en) Combination therapy for inhalation administration
RU2582218C2 (ru) Способ получения дозирующего распыляющего ингалятора для лечения респираторного заболевания
KR20060118509A (ko) 신규 화합물
HK1108390B (en) Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin
US9241904B1 (en) Method for preparing metered dose sprayed inhaler for treating respiratory disease
AU2015201037B2 (en) Respiratory delivery of active agents
HK1176550B (en) The preparation for formulation composition and manufacturing processes of metered does inhalers treated respiratory diseases
HK1176550A (en) The preparation for formulation composition and manufacturing processes of metered does inhalers treated respiratory diseases
NZ621362B2 (en) Method for preparing metered dose sprayed inhaler for treating respiratory disease

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060525

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20091124

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110530

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20120322

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20110530

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I